BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Dr Reddys Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500124
ISIN Demat
INE089A01031
Book Value (Rs)
377.5510998
NSE Symbol
DRREDDY
Divident Yield %
0.62
Market Cap
(Rs In Cr.)
107,942
P/E (TTM)
23.26
EPS (TTM)
55.59
Face Value
(Rs)
1
Date Heading
29-Apr-26 OneSource's partner Dr. Reddy's receives Health Canada approval for Se
23-Apr-26 Shree Ganesh Remedies Ltd Spikes 3.78%
06-Mar-26 Dr Reddy's Lab gets EIR from USFDA for Srikakulam facility
19-Feb-26 Dr. Reddy’s Labs acquires 'Progynova' portfolio from UK's Mercury Phar
19-Feb-26 Nifty drops below 25,650 mark; auto shares snap 2-day gains
22-Jan-26 Dr Reddy’s Lab Q3 PAT drops 14% YoY to Rs 1,210 cr
21-Jan-26 Dr Reddy's Laboratories consolidated net profit declines 14.42% in the
01-Jan-26 Dr Reddy’s Swiss subsidiary gets USFDA CRL for biosimilar AVT03
24-Dec-25 Dr Reddys Laboratories to announce Quarterly Result
09-Dec-25 Dr Reddys Laboratories allots 9,165 equity shares under ESOS
08-Dec-25 Dr Reddy’s Lab arm inks pact with Immutep SAS for novel cancer immunot
01-Dec-25 Dr Reddys Laboratories Ltd up for five straight sessions
25-Nov-25 Dr Reddys Lab gains after securing EC nod for AVT03
24-Nov-25 Dr. Reddy's receives EC marketing authorization for AVT03 (denosumab)
17-Nov-25 Dr Reddys Laboratories Ltd up for fifth session
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)